{"count": 5, "results": [{"_id": "36117030", "pmid": 36117030, "title": "Simvastatin encapsulated in exosomes can enhance its inhibition of relapse after orthodontic tooth movement.", "journal": "Am J Orthod Dentofacial Orthop", "authors": ["Liu X", "Muhammed FK", "Liu Y"], "date": "2022-12-01T00:00:00Z", "doi": "10.1016/j.ajodo.2021.07.025", "meta_date_publication": "2022 Dec", "meta_volume": "162", "meta_issue": "6", "meta_pages": "881-889", "score": 50271.527, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ encapsulated in exosomes can enhance its inhibition of relapse after orthodontic tooth @<m>DISEASE_Movement_Disorders</m> @DISEASE_MESH:D009069 @@@movement@@@.", "citations": {"NLM": "Liu X, Muhammed FK, Liu Y. Simvastatin encapsulated in exosomes can enhance its inhibition of relapse after orthodontic tooth movement. Am J Orthod Dentofacial Orthop. 2022 Dec;162(6):881-889. PMID: 36117030", "BibTeX": "@article{36117030, title={Simvastatin encapsulated in exosomes can enhance its inhibition of relapse after orthodontic tooth movement.}, author={Liu X and Muhammed FK and Liu Y}, journal={Am J Orthod Dentofacial Orthop}, volume={162}, number={6}, pages={881-889}}"}}, {"_id": "39284697", "pmid": 39284697, "title": "Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.", "journal": "BMJ Open", "authors": ["Blackstone J", "Williams T", "Nicholas JM", "Bordea E", "De Angelis F", "Bianchi A", "Calvi A", "Doshi A", "John N", "Apap Mangion S", "Wade C", "Merry R", "Barton G", "Lyle D", "Jarman E", "Mahad D", "Shehu A", "Arun T", "McDonnell G", "Geraldes R", "Craner M", "Hillier C", "Ganesalingam J", "Fisniku L", "Hobart J", "Spilker C", "Robertson N", "Kalra S", "Pluchino S", "Harikrishnan S", "Mattoscio M", "Harrower T", "Young C", "Lee M", "Chhetri S", "Ahmed F", "Rog D", "Silber E", "Gallagher P", "Duddy M", "Straukiene A", "Nicholas R", "Rice C", "Nixon SJ", "Beveridge J", "Hawton A", "Tebbs S", "Braisher M", "Giovannoni G", "Ciccarelli O", "Greenwood J", "Thompson AJ", "Hunter R", "Pavitt S", "Pearson O", "Evangelou N", "Sharrack B", "Galea I", "Chandran S", "Ford HL", "Frost C", "Chataway J"], "date": "2024-09-16T00:00:00Z", "doi": "10.1136/bmjopen-2024-086414", "meta_date_publication": "2024 Sep 16", "meta_volume": "14", "meta_issue": "9", "meta_pages": "e086414", "score": 50248.08, "text_hl": "Evaluating the effectiveness of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in slowing the progression of @<m>DISEASE_Movement_Disorders</m> @DISEASE_MESH:D009069 @@@disability@@@ in secondary progressive @DISEASE_Multiple_Sclerosis @DISEASE_MESH:D009103 @@@multiple sclerosis@@@ (@DISEASE_Multiple_Sclerosis @DISEASE_MESH:D009103 @@@MS@@@-@GENE_STAT2 @GENE_6773 @@@STAT2@@@): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.", "citations": {"NLM": "Blackstone J, Williams T, Nicholas JM, Bordea E, De Angelis F, Bianchi A, Calvi A, Doshi A, John N, Apap Mangion S, Wade C, Merry R, Barton G, Lyle D, Jarman E, Mahad D, Shehu A, Arun T, McDonnell G, Geraldes R, Craner M, Hillier C, Ganesalingam J, Fisniku L, Hobart J, Spilker C, Robertson N, Kalra S, Pluchino S, Harikrishnan S, Mattoscio M, Harrower T, Young C, Lee M, Chhetri S, Ahmed F, Rog D, Silber E, Gallagher P, Duddy M, Straukiene A, Nicholas R, Rice C, Nixon SJ, Beveridge J, Hawton A, Tebbs S, Braisher M, Giovannoni G, Ciccarelli O, Greenwood J, Thompson AJ, Hunter R, Pavitt S, Pearson O, Evangelou N, Sharrack B, Galea I, Chandran S, Ford HL, Frost C, Chataway J. Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK. BMJ Open. 2024 Sep 16;14(9):e086414. PMID: 39284697", "BibTeX": "@article{39284697, title={Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.}, author={Blackstone J and Williams T and Nicholas JM and Bordea E and De Angelis F and Bianchi A and Calvi A and Doshi A and John N and Apap Mangion S and Wade C and Merry R and Barton G and Lyle D and Jarman E and Mahad D and Shehu A and Arun T and McDonnell G and Geraldes R and Craner M and Hillier C and Ganesalingam J and Fisniku L and Hobart J and Spilker C and Robertson N and Kalra S and Pluchino S and Harikrishnan S and Mattoscio M and Harrower T and Young C and Lee M and Chhetri S and Ahmed F and Rog D and Silber E and Gallagher P and Duddy M and Straukiene A and Nicholas R and Rice C and Nixon SJ and Beveridge J and Hawton A and Tebbs S and Braisher M and Giovannoni G and Ciccarelli O and Greenwood J and Thompson AJ and Hunter R and Pavitt S and Pearson O and Evangelou N and Sharrack B and Galea I and Chandran S and Ford HL and Frost C and Chataway J}, journal={BMJ Open}, volume={14}, number={9}, pages={e086414}}"}}, {"_id": "15145635", "pmid": 15145635, "title": "Oral simvastatin treatment in relapsing-remitting multiple sclerosis.", "journal": "Lancet", "authors": ["Vollmer T", "Key L", "Durkalski V", "Tyor W", "Corboy J", "Markovic-Plese S", "Preiningerova J", "Rizzo M", "Singh I"], "date": "2004-05-15T00:00:00Z", "doi": "10.1016/S0140-6736(04)16205-3", "meta_date_publication": "2004 May 15", "meta_volume": "363", "meta_issue": "9421", "meta_pages": "1607-8", "score": 50060.01, "text_hl": "Treatment was well tolerated. Oral @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ might inhibit @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ components of @DISEASE_Multiple_Sclerosis @DISEASE_MESH:D009103 @@@multiple sclerosis@@@ that lead to @<m>DISEASE_Movement_Disorders</m> @DISEASE_MESH:D009069 @@@neurological disability@@@.", "citations": {"NLM": "Vollmer T, Key L, Durkalski V, Tyor W, Corboy J, Markovic-Plese S, Preiningerova J, Rizzo M, Singh I. Oral simvastatin treatment in relapsing-remitting multiple sclerosis. Lancet. 2004 May 15;363(9421):1607-8. PMID: 15145635", "BibTeX": "@article{15145635, title={Oral simvastatin treatment in relapsing-remitting multiple sclerosis.}, author={Vollmer T and Key L and Durkalski V and Tyor W and Corboy J and Markovic-Plese S and Preiningerova J and Rizzo M and Singh I}, journal={Lancet}, volume={363}, number={9421}, pages={1607-8}}"}}, {"_id": "24655729", "pmid": 24655729, "title": "Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial.", "journal": "Lancet", "authors": ["Chataway J", "Schuerer N", "Alsanousi A", "Chan D", "MacManus D", "Hunter K", "Anderson V", "Bangham CR", "Clegg S", "Nielsen C", "Fox NC", "Wilkie D", "Nicholas JM", "Calder VL", "Greenwood J", "Frost C", "Nicholas R"], "date": "2014-06-28T00:00:00Z", "doi": "10.1016/S0140-6736(13)62242-4", "meta_date_publication": "2014 Jun 28", "meta_volume": "383", "meta_issue": "9936", "meta_pages": "2213-21", "score": 50054.34, "text_hl": "Effect of high-dose @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @DISEASE_Microphthalmia_Syndromic_10 @DISEASE_MESH:C566985 @@@brain atrophy and@@@ @<m>DISEASE_Movement_Disorders</m> @DISEASE_MESH:D009069 @@@disability@@@ in @DISEASE_Multiple_Sclerosis_Chronic_Progressive @DISEASE_MESH:D020528 @@@secondary progressive multiple sclerosis@@@ (@DISEASE_Multiple_Sclerosis @DISEASE_MESH:D009103 @@@MS-STAT@@@): a randomised, placebo-controlled, phase 2 trial.", "citations": {"NLM": "Chataway J, Schuerer N, Alsanousi A, Chan D, MacManus D, Hunter K, Anderson V, Bangham CR, Clegg S, Nielsen C, Fox NC, Wilkie D, Nicholas JM, Calder VL, Greenwood J, Frost C, Nicholas R. Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial. Lancet. 2014 Jun 28;383(9936):2213-21. PMID: 24655729", "BibTeX": "@article{24655729, title={Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial.}, author={Chataway J and Schuerer N and Alsanousi A and Chan D and MacManus D and Hunter K and Anderson V and Bangham CR and Clegg S and Nielsen C and Fox NC and Wilkie D and Nicholas JM and Calder VL and Greenwood J and Frost C and Nicholas R}, journal={Lancet}, volume={383}, number={9936}, pages={2213-21}}"}}, {"_id": "31072935", "pmid": 31072935, "pmcid": "PMC6561162", "title": "Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis", "journal": "Proc Natl Acad Sci U S A", "authors": ["Eshaghi A", "Kievit RA", "Prados F", "Sudre CH", "Nicholas J", "Cardoso MJ", "Chan D", "Nicholas R", "Ourselin S", "Greenwood J", "Thompson AJ", "Alexander DC", "Barkhof F", "Chataway J", "Ciccarelli O"], "date": "2019-05-28T00:00:00Z", "doi": "10.1073/pnas.1818978116", "meta_date_publication": "2019 May 28", "meta_volume": "116", "meta_issue": "22", "meta_pages": "11020-11027", "score": 50053.348, "text_hl": "The challenge of understanding the mode of action of a medication is exemplified by the @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ trial, a phase 2 trial for secondary progressive @DISEASE_Multiple_Sclerosis @DISEASE_MESH:D009103 @@@MS@@@, in which MRI measures of @DISEASE_Atrophy @DISEASE_MESH:D001284 @@@atrophy@@@ and @<m>DISEASE_Movement_Disorders</m> @DISEASE_MESH:D009069 @@@clinical disability@@@ showed beneficial effects. ", "citations": {"NLM": "Eshaghi A, Kievit RA, Prados F, Sudre CH, Nicholas J, Cardoso MJ, Chan D, Nicholas R, Ourselin S, Greenwood J, Thompson AJ, Alexander DC, Barkhof F, Chataway J, Ciccarelli O. Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis Proc Natl Acad Sci U S A. 2019 May 28;116(22):11020-11027. PMID: 31072935", "BibTeX": "@article{31072935, title={Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis}, author={Eshaghi A and Kievit RA and Prados F and Sudre CH and Nicholas J and Cardoso MJ and Chan D and Nicholas R and Ourselin S and Greenwood J and Thompson AJ and Alexander DC and Barkhof F and Chataway J and Ciccarelli O}, journal={Proc Natl Acad Sci U S A}, volume={116}, number={22}, pages={11020-11027}}"}}]}